Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01593748
Title A Treatment Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medical University of South Carolina



Docetaxel + Gemcitabine

Gemcitabine + Pazopanib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.